Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MAX-001 by MAXONA Pharmaceuticals for Pain: Likelihood of Approval
MAX-001 is under clinical development by MAXONA Pharmaceuticals and currently in Phase I for Pain. According to GlobalData, Phase I...